For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe must meet exacting standards for dosage, purity, and sterility. This ...

Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...

In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...

Global pharmaceutical production surged in 2025 due to tariff-driven front-loading but is expected to slow as trade ...

New Delhi, Jan 29 (PTI) India’s pharmaceutical industry is shifting from a volume-driven to a value-driven approach, with ...

THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...